Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),123 providing the simplicity of a fully subcutaneous dose ...

C5aR1 plays an important role in the immune cascade that causes tissue inflammation, particularly in neutrophil-mediated conditions. There’s an obvious overlap with Biogen’s own izastobart, an ...

Cambridge, Massachusetts Friday, October 24, 2025, 18:00 Hrs [IST] ...

Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement strengthens ...

Researchers have revealed a novel mechanism by which the chromatin remodeler brahma-related gene 1 (Brg1) regulates Group 2 ...

The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed ...

Overture Life in Old East Dallas will use AI to predict which embryos will likely lead to successful pregnancies.

In a world-first breakthrough, scientists have discovered how a sugary “cloak” helps bowel cancer hide from the immune system ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...